Obesity trials in Romania

In Romania 16 Also abroad 1939

16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Brasov, Bucharest, Cluj-Napoca, Craiova, Jassi, Ploiesti, Timisoara
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Taking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Bacau, Bucharest, Constanța, Craiova, Timișoara
Age
18 years to 70 years
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
Phase 3Taking people
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Where
Bacau, Bucharest, Constanța, Craiova, Timișoara
Age
18 years to 70 years
People
290 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00
Phase 3Taking people
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Where
Brasov, Bucharest, Craiova, Oradea, Sibiu, Suceagu, Timisoara, Timișoara
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07202884 · EU 2025-522514-23-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Where
Brasov, Bucharest, Mangalia, Oradea, Satu Mare, Targoviste, Targu Mures, Timisoara
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00
Phase 3Taking people
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Where
Baia Mare, Brasov, Bucharest, Craiova, Galați, Mangalia, Oradea, Satu Mare
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00
Phase 3Not yet taking people in Romania
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Bacau, Baia Mare, Brasov, Bucharest, Craiova, Galati, Mangalia, Satu Mare, Targoviste
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Baia Mare, Brasov, Bucharest, Buzău, Iași, Piteşti, Târgu Mureş, Timisoara
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
Where
Baia Mare, Brasov, Bucharest, Buzău, Jassi, Pitesti, Targu Mures, Târgu Mureş, Timisoara
Age
18 years and over
People
2,787 worldwide
Run by
Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00
Phase 1/2Taking people
A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
Where
Bucharest, Cluj-Napoca
Age
18 years to 75 years
People
400 worldwide
Run by
Wave Life Sciences USA, Inc.
See details and how to joinNCT06842186 · EU 2024-520203-41-00
Phase 3Not yet taking people in Romania
Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
Where
Bacau, Baia Mare, Bucharest, Craiova, Galati, Iasi,, Jassi, Târgu Mureş, Timișoara
Age
18 years and over
People
3,000 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT07896265 · EU 2025-524861-26-00
Phase 3Taking people
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Where
Bucharest, Timisoara
Age
8 years to 18 years
People
460 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07253285 · EU 2023-509176-42-00
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Baia Mare, Brasov, Bucharest, Buzău, Craiova, Oradea, Pitesti, Târgu Mureş, Timisoara
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
Phase 3Not yet taking people in Romania
AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Where
Bacau, Bucharest, Oradea, Reghin, Satu Mare, Timisoara
Age
18 years and over
People
985 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07400107 · EU 2024-520446-31-00
Phase 2Taking people
Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
Where
Bucharest, Bucharest Sector 1
Age
45 years and over
People
600 worldwide
Run by
KeyBioscience AG
See details and how to joinNCT06833749 · EU 2024-517264-27-00
No phaseTaking people
Global Research Initiative for Patients Screening on MASH
Where
Săcele
Age
18 years to 75 years
People
10,000 worldwide
Run by
Julius Clinical
See details and how to joinNCT05651724